Imnovid Pomalidomide 1mg Capsule

Get a Price/Quote

MOQ : 10 Pieces

Imnovid Pomalidomide 1mg Capsule Specification

Indication
Multiple myeloma (for use in patients who have received at least two prior therapies including lenalidomide and bortezomib)

Salt Composition
Pomalidomide 1mg

Dosage Form
Capsule

Feature
Oral immunomodulatory agent for targeted cancer therapy

Ingredients
Pomalidomide and excipients

Application
Anticancer therapy

Physical Color/Texture
Hard gelatin capsule

Storage Instructions
Store below 25C, protect from moisture and light.

Shelf Life
24 months from the date of manufacture

Therapeutic Class
Immunomodulatory drug (IMiD)

ATC Code
L04AX06

International Availability
Available in multiple regulated markets

Packaging Size
21 capsules per box

Prescription Status
Prescription only medicine

Warning
Potential risk of birth defects; use strict contraception measures

Country Registration
Approved in Canada, EU, UK, USA, and Australia

Route of Administration
Oral

Pregnancy Category
Category X (contraindicated in pregnancy)

Imnovid Pomalidomide 1mg Capsule About

Imnovid Pomalidomide 1mg Capsule is a featured oral immunomodulatory drug acclaimed for its efficacy in targeted multiple myeloma therapy. Manufactured to impeccable standards, these kingly capsules contain 21 units per box and are available internationally, boasting registration in Canada, the EU, UK, USA, and Australia. Imnovid is prescription-only, strictly contraindicated in pregnancy, and classified as ATC Code L04AX06. Patients enjoy a discount when sourced through approved suppliers in India. Each capsule's towering formulation assists those needing advanced therapies, with a 24-month shelf life when stored below 25C.

Key Features and Application of Imnovid Pomalidomide 1mg Capsule

Imnovid Pomalidomide 1mg Capsule stands out with its impeccable oral formulation, delivering targeted immunomodulatory action for patients with relapsed or refractory multiple myeloma. This acclaimed product is used as an anticancer therapy, especially in individuals who have undergone at least two prior treatments including lenalidomide and bortezomib. Its kingly effectiveness supports advanced cancer care, and its hard gelatin capsule ensures optimal delivery. Physicians prescribe Imnovid strictly under medical supervision for enhanced patient outcomes.

Sample Policy, Certifications, and Delivery of Imnovid Pomalidomide 1mg Capsule

Purchase orders for Imnovid samples are handled through authorized channels to ensure compliance with international certifications. Buyers can anticipate efficient transportation and timely delivery, with products shipped under specified conditions to ensure product integrity. The sample policy follows regulated guidelines, offering sale price transparency for healthcare providers. Depending on the location, delivery time varies but is always optimized for rapid access. Certified suppliers in India manage the trading, ensuring safety and authenticity with each purchase.

FAQ's of Imnovid Pomalidomide 1mg Capsule:

Q: How should Imnovid Pomalidomide 1mg Capsule be stored after purchase?

A: Imnovid Pomalidomide 1mg Capsules should be stored below 25C, protected from moisture and light, to maintain their stability and efficacy throughout the 24-month shelf life.

Q: What specific patients are eligible to use Imnovid Pomalidomide 1mg Capsule?

A: Imnovid is indicated for patients with multiple myeloma who have received at least two prior therapies, including lenalidomide and bortezomib, as prescribed by a healthcare professional.

Q: What are the main features that distinguish Imnovid Pomalidomide 1mg Capsule from other capsules?

A: Imnovid is a featured oral immunomodulatory drug, acclaimed for its targeted action against multiple myeloma and its robust efficacy in patients unresponsive to previous treatments.

Q: Where has Imnovid Pomalidomide 1mg Capsule been approved for use?

A: Imnovid is internationally available and has regulatory approval in Canada, the EU, UK, USA, and Australia, which ensures its use in multiple regulated markets.

Q: What warnings must be observed during the usage of Imnovid Pomalidomide 1mg Capsule?

A: Due to its Pregnancy Category X status, Imnovid presents a potential risk of birth defects; strict contraception measures must be followed throughout and after treatment.

Tell us about your requirement